87380 Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; hepatitis, delta agent

Name of the Procedure:

Infectious agent antigen detection by immunoassay technique, commonly known as Enzyme Immunoassay (EIA), Enzyme-Linked Immunosorbent Assay (ELISA), or Immunochemiluminometric Assay (IMCA) for hepatitis delta agent (HDV).

Summary

The procedure is a laboratory test used to detect the presence of hepatitis delta virus (HDV) antigens in a blood sample. It uses specialized techniques to identify and measure proteins that indicate an infection with HDV.

Purpose

The primary purpose of this procedure is to diagnose hepatitis delta virus infection. It helps in detecting the virus in the blood, which is crucial for guiding treatment and management.

Indications

• Symptoms such as jaundice, fatigue, abdominal pain, and liver enlargement.
• Elevated liver enzymes in blood tests.
• Known hepatitis B infection, as HDV only infects individuals with hepatitis B.
• Individuals at high risk of HDV due to intravenous drug use or other risk factors.

Preparation

• No specific fasting or dietary changes are required.
• Inform your healthcare provider about any medications or supplements you are taking.
• Blood sample will be collected, so it may be useful to stay hydrated.

Procedure Description

1. A healthcare provider will collect a blood sample, usually from a vein in your arm, using a needle and syringe.
2. The sample is sent to the laboratory for analysis.
3. In the lab, the sample undergoes processing using one of the immunoassay techniques (EIA, ELISA, or IMCA) to detect HDV antigens.
4. The assay involves multiple steps, including binding of antigens to antibodies, washing, and detection using enzymes or chemiluminescent markers.
5. Results are interpreted qualitatively (positive/negative) or semiquantitatively (concentration levels).

Duration

The blood draw typically takes around 5-10 minutes. Laboratory processing and result interpretation may take several hours to a few days, depending on the facility.

Setting

The blood sample collection is generally done in a hospital, outpatient clinic, or diagnostic laboratory setting.

Personnel

• Phlebotomist or nurse for blood sample collection.
• Medical laboratory technologist for processing and analyzing the sample.
• Physician or specialist to interpret the results and discuss them with the patient.

Risks and Complications

• Minor pain or bruising at the site of blood draw.
• Rarely, infection at the puncture site.
• Potential false positives or negatives, necessitating further testing.

Benefits

• Accurate and specific diagnosis of HDV infection.
• Aids in the timely initiation of treatment.
• Helps in monitoring disease progression and response to therapy.

Recovery

• Minimal recovery time required post blood draw.
• Patients can resume normal activities immediately after the procedure.
• Follow-up with your healthcare provider for results interpretation and next steps.

Alternatives

• Liver biopsy or imaging studies for indirect assessment of liver inflammation and damage.
• Polymerase Chain Reaction (PCR) tests to detect HDV RNA.
• Serological tests for hepatitis B markers since HDV co-infects with HBV.

Patient Experience

• You might feel a slight prick or sting during the blood draw.
• Generally, the discomfort is minimal and short-lived.
• Any pain or bruising at the puncture site typically resolves quickly.
• Results discussion with your doctor will provide clarity on diagnosis and next steps.